Biohaven

Biohaven Treasury Stock

The Treasury Stock of Biohaven (BHVN) as of Nov 16, 2026 is 193.98 M USD. In the previous year, Treasury Stock was 112.37 M USD — a change of 72.63% (higher).

Treasury Stock

193.98 MUSD

YoY

72.63%

Last updated:

Treasury Stock of Biohaven is 2025 193.98 M USD. Treasury Stock of Biohaven was 2024 112.37 M USD. It decreases by 72.63% higher compared to the previous year.

The Biohaven Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2018
40.41 M USD
Jan 1, 2019
84.46 M USD
Jan 1, 2020
98.94 M USD
Jan 1, 2021
169.66 M USD
Jan 1, 2022
13.87 M USD
Jan 1, 2023
39.80 M USD
Jan 1, 2024
112.37 M USD
Jan 1, 2025
193.98 M USD
The Biohaven Treasury Stock history
YEARTreasury StockYoY
193.98 MUSD+72.63%
112.37 MUSD+182.31%
39.80 MUSD+187.00%
13.87 MUSD-91.83%
169.66 MUSD+71.48%
98.94 MUSD+17.15%
84.46 MUSD+109.01%
40.41 MUSD+71.22%
23.60 MUSD+125.03%
10.49 MUSD+146.12%
4.26 MUSD-952.20%
-500,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohaven Stock analysis

What does Biohaven do? Biohaven Pharmaceutical Holding Co. Ltd. generates revenue through the research and development of late-stage product candidates targeting neurological diseases and rare disorders. The company utilizes its glutamate platform to advance clinical-stage compounds for various indications, including trigriluzole for obsessive-compulsive disorder, spinocerebellar ataxia, and Alzheimer's disease. Additionally, the firm develops BHV-0223 for amyotrophic lateral sclerosis and BHV-5000 for conditions such as Rett syndrome, neuropathic pain, and treatment-resistant depression. The business model focuses on identifying and developing clinical-stage compounds that target orphan neurologic indications and other neurological pathways, with the company currently employing 825 full-time employees in New Haven, Connecticut. Biohaven is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biohaven stock

Treasury Stock of Biohaven is 193.98 M USD in 2025.

Treasury Stock of Biohaven changed from 112.37 M USD to 193.98 M USD, representing a 72.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Biohaven since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Biohaven historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biohaven

All Key Metrics — Biohaven